PTEN and neoplasm: These tumours respond to RT, retain androgen receptor (AR) expression and sensitivity to androgens, and display an immune ‘cold’ phenotype with tumours being poorly infiltrated by T-cells, and heavily infiltrated with myeloid cells, which is primarily driven by Pten loss [13].